To determine the malignant characteristics of PCNA V3 and V4 variants in vitro and identify a good model of knockdown, we analyzed the mRNA expression in 25 cancer cell lines by means of quantitative RT-PCR (Figure S3). The gene discussed is PCNA; the disease is cancer.